ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 263,869 Value ($000) $6,069 Avg Close $32.88 Range $18.41 - $39.89
Q3 2025
Shares 78,922 Value ($000) $2,374 Avg Close $29.99 Range $25.81 - $42.37
Q2 2025
Shares 5,885 Value ($000) $214 Avg Close $36.05 Range $29.59 - $40.19
Q1 2025
Shares 44,901 Value ($000) $1,626 Avg Close $41.60 Range $35.53 - $46.50
Q4 2024
Shares 27,016 Value ($000) $1,137 Avg Close $49.61 Range $41.26 - $57.99
Q3 2024
Shares 75,265 Value ($000) $4,181 Avg Close $50.94 Range $39.65 - $60.37
Q2 2024
Shares 162,891 Value ($000) $6,695 Avg Close $42.70 Range $37.02 - $52.56
Q1 2024
Shares 155,525 Value ($000) $7,261 Avg Close $47.17 Range $41.87 - $54.56
Q4 2023
Shares 86,457 Value ($000) $4,134 Avg Close $38.77 Range $31.52 - $49.93
Q3 2023
Shares 182,235 Value ($000) $6,497 Avg Close $39.62 Range $34.33 - $47.08
Q2 2023
Shares 206,031 Value ($000) $9,504 Avg Close $46.38 Range $37.20 - $54.98
Q1 2023
Shares 207,858 Value ($000) $8,335 Avg Close $42.91 Range $35.72 - $49.31
Q4 2022
Shares 230,194 Value ($000) $10,665 Avg Close $39.33 Range $33.36 - $46.51
Q3 2022
Shares 188,421 Value ($000) $7,803 Avg Close $51.39 Range $39.55 - $68.68
Q2 2022
Shares 32,581 Value ($000) $1,944 Avg Close $61.54 Range $45.20 - $85.53
Q2 2021
Shares 2,357 Value ($000) $225 Avg Close $104.18 Range $91.93 - $120.00
Q1 2021
Shares 15,466 Value ($000) $1,761 Avg Close $136.14 Range $102.90 - $175.00
Q4 2020
Shares 2,626 Value ($000) $364 Avg Close $118.63 Range $82.43 - $179.65
Q2 2015
Shares 3,800 Value ($000) $389 Avg Close $77.65 Range $56.11 - $105.97
Q1 2015
Shares 5,300 Value ($000) $329 Avg Close $55.55 Range $44.27 - $65.35